These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 17536214

  • 1. Administration of anti-IgE to a Churg-Strauss syndrome patient.
    Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, Kalil J.
    Int Arch Allergy Immunol; 2007; 144(2):155-8. PubMed ID: 17536214
    [Abstract] [Full Text] [Related]

  • 2. Churg-Strauss vasculitis in a patient treated with omalizumab.
    Bargagli E, Madioni C, Olivieri C, Penza F, Rottoli P.
    J Asthma; 2008 Mar; 45(2):115-6. PubMed ID: 18350402
    [Abstract] [Full Text] [Related]

  • 3. Churg-strauss syndrome in patients treated with omalizumab.
    Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L.
    Chest; 2009 Aug; 136(2):507-518. PubMed ID: 19411292
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.
    Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, Lenczewska D, Bodzenta-Lukaszyk A.
    Int Arch Allergy Immunol; 2011 Aug; 154(1):25-32. PubMed ID: 20664274
    [Abstract] [Full Text] [Related]

  • 10. [Churg-Strauss syndrome: clinical features and long-term follow-up of 16 patients].
    Lou J, Xu WB.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 03; 89(8):524-8. PubMed ID: 19567070
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical features of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Association with asthma symptoms].
    Higashimoto I, Umehara F, Koreeda Y, Watanabe T, Kawabata M, Arimura K, Osame M.
    Arerugi; 1996 Nov 03; 45(11):1154-60. PubMed ID: 8990526
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD, Omalizumab 011 International Study Group.
    Clin Exp Allergy; 2004 Apr 03; 34(4):632-8. PubMed ID: 15080818
    [Abstract] [Full Text] [Related]

  • 14. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr 03; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical manifestations and treatment of Churg-Strauss syndrome.
    Baldini C, Talarico R, Della Rossa A, Bombardieri S.
    Rheum Dis Clin North Am; 2010 Aug 03; 36(3):527-43. PubMed ID: 20688248
    [Abstract] [Full Text] [Related]

  • 17. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
    Shimizu Y, Dobashi K, Fueki N, Fueki M, Okada T, Tomioka S, Makino S, Mori M.
    J Biol Regul Homeost Agents; 2011 Aug 03; 25(2):177-86. PubMed ID: 21880206
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-IgE therapy in persistent allergic asthma].
    Skiepko R, Zietkowski Z, Tomasiak-Łozowska MM, Bodzenta-Łukaszyk A.
    Przegl Lek; 2009 Aug 03; 66(3):141-4. PubMed ID: 19689039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.